Inducible Ulk1 expression activates the p53 protein in mouse embryonic stem cells

Area of Science:

• Cell Biology
• Developmental Biology
• Molecular Biology

Background:

• Pluripotent cells in early embryos are eliminated if defective, likely through the p53 pathway.
• The precise mechanism of p53 activation in this context remains unclear.
• Embryonic stem cells (ESCs) share similarities with preimplantation blastocyst cells, suggesting analogous elimination pathways.

Purpose of the Study:

• To investigate the mechanism of p53 activation in embryonic stem cells (ESCs).
• To explore the role of Ulk1 in p53 activation and the elimination of defective pluripotent cells.

Main Methods:

• Utilized a mouse ESC cell line with inducible Ulk1 gene expression.
• Monitored p53 phosphorylation on Ser15 following Ulk1 overexpression.
• Assessed ESC response to Ulk1 overexpression and subsequent retinoic acid treatment.

Main Results:

• Ulk1 upregulation in ESCs correlated with p53 phosphorylation at Ser15.
• ESCs overexpressing Ulk1 tolerated activated p53 without apoptosis or cell cycle arrest.
• Retinoic acid treatment induced massive cell death in Ulk1-overexpressing ESCs.

Conclusions:

• Ulk1 upregulation can activate the p53 pathway in ESCs.
• Ulk1-induced p53 activation appears to play a role in eliminating defective pluripotent cells before differentiation.
• This finding sheds light on the mechanisms governing the removal of abnormal cells during early development.